Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer-Reference-Cited by-同舟云学术

Risk-adaptive paradigm for focal versus whole-gland salvage treatment for radio-recurrent prostate cancer

Published:2022-09-29 Issue: Volume:12 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

King Martin T.,Yang David D.,D’Amico Anthony V.,Buzurovic Ivan,Harris Thomas C.,Guthier Christian V.,Steele Graeme S.,Kathrins Martin N.,Choudhury Atish D.

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference33 articles.

1. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J Natl Compr Cancer Netw JNCCN,2019

2. High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial;Zapatero;Lancet Oncol,2022

3. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer–updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: A systematic review and meta-analysis;Perera;Eur Urol,2020

4. A prospective study on 18F-DCFPyL PSMA PET/CT imaging in biochemical recurrence of prostate cancer;Rousseau;J Nucl Med,2019

5. Patterns of prostate cancer recurrence after brachytherapy determined by prostate-specific membrane antigen–positron emission tomography and computed tomography imaging;Raman;Int J Radiat Oncol,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study;Physics in Medicine & Biology;2024-08-21

2. Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2024-02-22

3. Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort;La radiologia medica;2023-09-20

4. Focal versus whole gland salvage brachytherapy for recurrent prostate cancer in the prostate specific membrane antigen era: a narrative review;Chinese Clinical Oncology;2023-06